Key result
Aged T-cell transfer accelerates Ang II-induced cardiovascular and renal fibrosis vs young T cells in mice.
Why the study?
The role of T-cell senescence in angiotensin II-induced target organ impairment and its underlying mechanisms were not well understood.
Does adoptive transfer of aged T cells accelerate Angiotensin II-induced target organ damage compared to young T cells in RAG1 KO mice?
Does adoptive transfer of aged T cells accelerate Angiotensin II-induced target organ damage compared to young T cells in RAG1 KO mice?
Senescent T cells exacerbate angiotensin II-induced cardiovascular and renal dysfunction via increased IFN-γ production, suggesting a potential therapeutic target for elderly hypertensive patients.
T-cell senescence may exacerbate Ang II-mediated organ damage in aging; hypothesis-generating for immunomodulatory strategies in hypertension.
AIMS: Aging is a risk factor for cardiovascular diseases and adaptive immunity has been implicated in angiotensin (Ang) II-induced target organ dysfunction. Herein, we sought to determine the role of T-cell senescence in Ang II-induced target organ impairment and to explore the underlying mechanisms. METHODS AND RESULTS: Flow cytometric analysis revealed that T cell derived from aged mice exhibited immunosenescence. Adoptive transfer of aged T cells to immunodeficient RAG1 KO mice accelerates Ang II-induced cardiovascular and renal fibrosis compared with young T-cell transfer. Aged T cells also promote inflammatory factor expression and superoxide production in these target organs. In vivo and in vitro studies revealed that Ang II promotes interferon-gamma (IFN-γ) production in the aged T cells comparing to young T cells. Importantly, transfer of senescent T cell that IFN-γ KO mitigates the impairment. Aged T-cell-conditioned medium stimulates inflammatory factor expression and oxidative stress in Ang II-treated renal epithelial cells compared with young T cells, and these effects of aged T-cell-conditioned medium are blunted after IFN-γ-neutralizing antibody pre-treatment. CONCLUSION: These results provide a significant insight into the contribution of senescent T cells to Ang II-induced cardiovascular dysfunction and provide an attractive possibility that targeting T cell specifically might be a potential strategy to treat elderly hypertensive patients with end-organ dysfunction.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2020) studied Angiotensin II-induced target organ damage. Adoptive transfer of aged T cells vs. Young T-cell transfer was evaluated on Cardiovascular and renal fibrosis, inflammatory factor expression, and superoxide production. Adoptive transfer of aged T cells accelerated Angiotensin II-induced cardiovascular and renal fibrosis and promoted inflammatory factor expression compared with young T-cell transfer in mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: